Loading...

Rawson Richard

TitleProfessor
InstitutionUniversity of California Los Angeles
DepartmentPsychiatry and Biobehavioral Sciences
AddressUCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd Suite 200
Los Angeles CA 90025
Phone310-312-0538
vCardDownload vCard
    Other Positions
    TitleCo-Director


    Collapse Research 
    Collapse Research Activities and Funding
    Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)
    NIH/NIDA UG3DA044830Aug 15, 2017 - Jul 31, 2019
    Role: Co-Principal Investigator
    HIV-Addiction Technology Transfer Center North and South
    SAMHSA/CSAT UD1TI025911Sep 1, 2014 - Aug 31, 2017
    Role: Principal Investigator
    SBIRT for Substance Abuse in Mental Health Treatment Settings
    NIH/NIDA R01DA032733Sep 15, 2012 - Aug 31, 2017
    Role: Co-Principal Investigator
    UCLA - Cairo University Addiction Unit Research Training Program
    NIH/FIC D43TW009102Aug 31, 2012 - Feb 28, 2016
    Role: Principal Investigator
    Vietnam HIV-Addiction Technology Transfer Center: VHATTC
    SAMHSA/CSAT UD1TI023603Sep 1, 2011 - Aug 31, 2014
    Role: Principal Investigator
    Drug Demand Reduction Initiative for Iraq
    SAMHSA/CSAT U79TI023450Aug 1, 2011 - Mar 31, 2013
    Role: Principal Investigator
    Aerobic Exercise to Improve Outcomes of Treatment for Methamphetamine Dependence
    NIH/NIDA R01DA027633Sep 30, 2009 - Aug 31, 2015
    Role: Principal Investigator
    Pacific Southwest Addiction Technology Transfer Center
    SAMHSA/CSAT UD1TI013594Sep 30, 2007 - Jan 31, 2013
    Role: Co-Principal Investigator
    PSYCHOSOCIAL TREATMENT DOSE--A PROSPECTIVE STUDY
    NIH/NIDA R01DA011972Jan 1, 1999 - Jun 30, 2004
    Role: Principal Investigator
    BEHAVIORAL/COGNITIVE BEHAVIORAL TRIAL FOR COCAINE ABUSE
    NIH/NIDA R01DA009419Sep 30, 1994 - Jun 30, 2000
    Role: Principal Investigator
    STRUCTURED MANUAL TO FACILITATE NALTREXONE TREATMENT
    NIH/NIDA R44DA007641Sep 1, 1993 - Aug 31, 1995
    Role: Principal Investigator
    ISAP Training Program in Addiction Health Services Research
    NIH/NIDA T32DA007272Sep 30, 1991 - Jun 30, 2018
    Role: Co-Principal Investigator
    A STRUCTURED MANUAL TO FACILITATE NALTREXONE TREATMENT
    NIH/NIDA R43DA007641Sep 30, 1991 - Mar 29, 1992
    Role: Principal Investigator
    OUTPATIENT ALCOHOLISM TREATMENT NEUROBEHAVIORAL MODEL
    NIH/NIAAA R43AA008971May 1, 1991 - Oct 31, 1991
    Role: Principal Investigator
    A NEUROBAVIORAL MODEL FOR OUTPATIENT COCAINE TREATMENT
    NIH/NIDA R44DA005778Jan 1, 1990 - Dec 31, 1991
    Role: Principal Investigator
    TREATMENT OF STIMULANT USERS TO REDUCE HIV TRANSMISSION
    NIH/NIDA R18DA006185Sep 30, 1989 - Aug 31, 1994
    Role: Principal Investigator
    NEUROBEHAVIORAL MODEL FOR OUTPATIENT COCAINE TREATMENT
    NIH/NIDA R43DA005778Sep 30, 1988 - Mar 31, 1989
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wolitzky-Taylor K, Drazdowski TK, Niles A, Roy-Byrne P, Ries R, Rawson R, Craske MG. Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users. Behav Res Ther. 2018 May 24; 107:34-41. PMID: 29852309.
      View in: PubMed
    2. Wolitzky-Taylor K, Niles AN, Ries R, Krull JL, Rawson R, Roy-Byrne P, Craske M. Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disorders. Behav Res Ther. 2018 May 17; 107:1-9. PMID: 29800622.
      View in: PubMed
    3. Wolitzky-Taylor K, Krull J, Rawson R, Roy-Byrne P, Ries R, Craske MG. Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics. J Consult Clin Psychol. 2018 Jan; 86(1):81-88. PMID: 29300100.
      View in: PubMed
    4. Krebs E, Enns B, Evans E, Urada D, Anglin MD, Rawson RA, Hser YI, Nosyk B. Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California. Ann Intern Med. 2018 Jan 02; 168(1):10-19. PMID: 29159398.
      View in: PubMed
    5. Crèvecoeur-MacPhail D, Cousins SJ, Denering L, Kim T, Rawson RA. Effectiveness of extended release naltrexone to reduce alcohol cravings and use behaviors during treatment and at follow-up. J Subst Abuse Treat. 2018 Feb; 85:105-108. PMID: 29174308.
      View in: PubMed
    6. Chokron Garneau H, Venegas A, Rawson R, Ray LA, Glasner S. Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders. J Subst Abuse Treat. 2018 Feb; 85:34-37. PMID: 28527854.
      View in: PubMed
    7. Elkashef A, Alhyas L, Al Hashmi H, Mohammed D, Gonzalez A, Paul R, Wanigaratne S, Gawad T, Rawson R, Al Marzooqi A, Al Ghaferi H. National Rehabilitation Center programme performance measures in the United Arab Emirates, 2013. East Mediterr Health J. 2017 May 01; 23(3):182-188. PMID: 28493265.
      View in: PubMed
    8. Al-Hemiery N, Dabbagh R, Hashim MT, Al-Hasnawi S, Abutiheen A, Abdulghani EA, Al-Diwan JK, Kak N, Al Mossawi H, Maxwell JC, Brecht ML, Antonini V, Hasson A, Rawson RA. Self-reported substance use in Iraq: findings from the Iraqi National Household Survey of Alcohol and Drug Use, 2014. Addiction. 2017 Aug; 112(8):1470-1479. PMID: 28238214.
      View in: PubMed
    9. Cousins SJ, Crèvecoeur-MacPhail D, Kim T, Rawson RA. The Los Angeles County hub-and-provider network for promoting the sustained use of extended-release naltrexone (XR-NTX) in Los Angeles County (2010-2015). J Subst Abuse Treat. 2018 Feb; 85:78-83. PMID: 28291571.
      View in: PubMed
    10. Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R. Trends in Tramadol: Pharmacology, Metabolism, and Misuse. Anesth Analg. 2017 01; 124(1):44-51. PMID: 27861439.
      View in: PubMed
    11. Glasner-Edwards S, Mooney LJ, Ang A, Garneau HC, Hartwell E, Brecht ML, Rawson RA. Mindfulness Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial. Mindfulness (N Y). 2017 Feb; 8(1):126-135. PMID: 28191264.
      View in: PubMed
    12. Padwa H, Urada D, Gauthier P, Rieckmann T, Hurley B, Crèvecouer-MacPhail D, Rawson RA. Organizing Publicly Funded Substance Use Disorder Treatment in the United States: Moving Toward a Service System Approach. J Subst Abuse Treat. 2016 10; 69:9-18. PMID: 27568505.
      View in: PubMed
    13. Glasner-Edwards S, Patrick K, Ybarra ML, Reback CJ, Rawson RA, Chokron Garneau H, Chavez K, Venegas A. A Cognitive Behavioral Therapy-Based Text Messaging Intervention Versus Medical Management for HIV-Infected Substance Users: Study Protocol for a Pilot Randomized Trial. JMIR Res Protoc. 2016 Jun 24; 5(2):e131. PMID: 27341852; PMCID: PMC4938885.
    14. Cousins SJ, Radfar SR, Crèvecoeur-MacPhail D, Ang A, Darfler K, Rawson RA. Predictors of Continued Use of Extended-Released Naltrexone (XR-NTX) for Opioid-Dependence: An Analysis of Heroin and Non-Heroin Opioid Users in Los Angeles County. J Subst Abuse Treat. 2016 Apr; 63:66-71. PMID: 26823295.
      View in: PubMed
    15. Robertson CL, Ishibashi K, Chudzynski J, Mooney LJ, Rawson RA, Dolezal BA, Cooper CB, Brown AK, Mandelkern MA, London ED. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment. Neuropsychopharmacology. 2016 May; 41(6):1629-36. PMID: 26503310; PMCID: PMC4832026 [Available on 05/01/17].
    16. Rawson RA, Chudzynski J, Mooney L, Gonzales R, Ang A, Dickerson D, Penate J, Salem BA, Dolezal B, Cooper CB. Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care. Drug Alcohol Depend. 2015 Nov 01; 156:21-28. PMID: 26371404; PMCID: PMC4633370 [Available on 11/01/16].
    17. Cousins SJ, Denering L, Crèvecoeur-MacPhail D, Viernes J, Sugita W, Barger J, Kim T, Weimann S, Rawson RA. A demonstration project implementing extended-release naltrexone in Los Angeles County. Subst Abus. 2016; 37(1):54-62. PMID: 26158698.
      View in: PubMed
    18. Rawson RA, Chudzynski J, Gonzales R, Mooney L, Dickerson D, Ang A, Dolezal B, Cooper CB. The Impact of Exercise On Depression and Anxiety Symptoms Among Abstinent Methamphetamine-Dependent Individuals in A Residential Treatment Setting. J Subst Abuse Treat. 2015 Oct; 57:36-40. PMID: 25934458; PMCID: PMC4560957 [Available on 10/01/16].
    19. Haglund M, Ang A, Mooney L, Gonzales R, Chudzynski J, Cooper CB, Dolezal BA, Gitlin M, Rawson RA. Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention. Am J Addict. 2015 Apr; 24(3):246-51. PMID: 25907813.
      View in: PubMed
    20. Rawson RA, Woody G, Kresina TF, Gust S. The globalization of addiction research: capacity-building mechanisms and selected examples. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):147-56. PMID: 25747927; PMCID: PMC4356020.
    21. Radfar SR, Sedaghat A, Banihashemi AT, Gouya M, Rawson RA. Behaviors Influencing Human Immunodeficiency Virus Transmission in the Context of Positive Prevention among People Living with HIV/Acquired Immunodeficiency Syndrome in Iran: A Qualitative Study. Int J Prev Med. 2014 Aug; 5(8):976-83. PMID: 25489445; PMCID: PMC4258663.
    22. Nosyk B, Li L, Evans E, Urada D, Huang D, Wood E, Rawson R, Hser YI. Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012. Drug Alcohol Depend. 2014 Oct 01; 143:149-57. PMID: 25110333; PMCID: PMC4484858.
    23. Radfar SR, Rawson RA. Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts. Addict Health. 2014 Summer-Autumn; 6(3-4):146-54. PMID: 25984282; PMCID: PMC4354220.
    24. Dolezal BA, Chudzynski J, Dickerson D, Mooney L, Rawson RA, Garfinkel A, Cooper CB. Exercise training improves heart rate variability after methamphetamine dependency. Med Sci Sports Exerc. 2014 Jun; 46(6):1057-66. PMID: 24162556; PMCID: PMC3999306.
    25. Al-Hemiary NJ, Al-Diwan JK, Hasson AL, Rawson RA. Drug and alcohol use in Iraq: findings of the inaugural Iraqi Community Epidemiological Workgroup. Subst Use Misuse. 2014 Nov; 49(13):1759-63. PMID: 24827867; PMCID: PMC4431571.
    26. Urada D, Teruya C, Gelberg L, Rawson R. Integration of substance use disorder services with primary care: health center surveys and qualitative interviews. Subst Abuse Treat Prev Policy. 2014 Mar 28; 9:15. PMID: 24679108; PMCID: PMC3978198.
    27. Rawson RA, Rieckmann T, Gust SW. Addiction Science: A Rationale and Tools for a Public Health Response to Drug Abuse. Public Health Rev. 2014; 35(2). PMID: 26752803.
      View in: PubMed
    28. Giang LM, Ngoc LB, Hoang VH, Mulvey K, Rawson RA. Substance use disorders and HIV in Vietnam since Doi Moi (Renovation): an overview. J Food Drug Anal. 2013 Dec; 21(4):S42-S45. PMID: 25278736.
      View in: PubMed
    29. Hser YI, Chang L, Wang GJ, Li MD, Rawson R, Shoptaw S, Normand J, Tai B. Capacity building and collaborative research on cross-national studies in the Asian region. J Food Drug Anal. 2013 Dec 01; 21(4):S117-S122. PMID: 24567700.
      View in: PubMed
    30. Rawson RA. Current research on the epidemiology, medical and psychiatric effects, and treatment of methamphetamine use. J Food Drug Anal. 2013 Dec; 21(4):S77-S81. PMID: 25214749.
      View in: PubMed
    31. Mooney LJ, Cooper C, London ED, Chudzynski J, Dolezal B, Dickerson D, Brecht ML, Peñate J, Rawson RA. Exercise for methamphetamine dependence: rationale, design, and methodology. Contemp Clin Trials. 2014 Jan; 37(1):139-47. PMID: 24291456; PMCID: PMC4431553.
    32. Farabee D, McCann M, Brecht ML, Cousins SJ, Antonini VP, Lee AB, Hemberg J, Karno M, Rawson RA. An analysis of relapse prevention factors and their ability to predict sustained abstinence following treatment completion. Am J Addict. 2013 May-Jun; 22(3):206-11. PMID: 23617860; PMCID: PMC4437594.
    33. Glasner-Edwards S, Mooney LJ, Ang A, Hillhouse M, Rawson R. Does Posttraumatic Stress Disorder (PTSD) Affect Post-Treatment Methamphetamine Use? J Dual Diagn. 2013 Apr 01; 9(2):123-128. PMID: 24065875.
      View in: PubMed
    34. Dolezal BA, Chudzynski J, Storer TW, Abrazado M, Penate J, Mooney L, Dickerson D, Rawson RA, Cooper CB. Eight weeks of exercise training improves fitness measures in methamphetamine-dependent individuals in residential treatment. J Addict Med. 2013 Mar-Apr; 7(2):122-8. PMID: 23552821; PMCID: PMC3617407.
    35. Rawson RA, Rataemane S, Rataemane L, Ntlhe N, Fox RS, McCuller J, Brecht ML. Dissemination and implementation of cognitive behavioral therapy for stimulant dependence: a randomized trial comparison of 3 approaches. Subst Abus. 2013; 34(2):108-17. PMID: 23577903; PMCID: PMC3625982.
    36. Ma JZ, Johnson BA, Yu E, Weiss D, McSherry F, Saadvandi J, Iturriaga E, Ait-Daoud N, Rawson RA, Hrymoc M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D, McCann M, Pham T, Stock C, Dickinson R, Elkashef A, Li MD. Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):45-51. PMID: 23142494.
      View in: PubMed
    37. Karno M, Farabee D, Brecht ML, Rawson R. Patient reactance moderates the effect of directive telephone counseling for methamphetamine users. J Stud Alcohol Drugs. 2012 Sep; 73(5):844-50. PMID: 22846250; PMCID: PMC3410952.
    38. Padwa H, Urada D, Antonini VP, Ober A, Crèvecoeur-MacPhail DA, Rawson RA. Integrating substance use disorder services with primary care: the experience in California. J Psychoactive Drugs. 2012 Sep-Oct; 44(4):299-306. PMID: 23210378; PMCID: PMC3664544.
    39. Rawson RA, Gonzales R, Greenwell L, Chalk M. Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups. J Psychoactive Drugs. 2012 Sep-Oct; 44(4):342-9. PMID: 23210383; PMCID: PMC4018415.
    40. Cousins SJ, Antonini VP, Rawson RA. Utilization, measurement, and funding of recovery supports and services. J Psychoactive Drugs. 2012 Sep-Oct; 44(4):325-33. PMID: 23210381.
      View in: PubMed
    41. Rutkowski BA, Rawson RA, Freese TE. Editors' introduction: The evidence for integrated care-substance use disorders, mental health and primary care: California Substance Abuse Research Consortium (SARC) meetings, 2011. J Psychoactive Drugs. 2012 Sep-Oct; 44(4):281-4. PMID: 23210375.
      View in: PubMed
    42. Urada D, Schaper E, Alvarez L, Reilly C, Dawar M, Field R, Antonini V, Oeser B, Crèvecoeur-MacPhail D, Rawson RA. Perceptions of mental health and substance use disorder services integration among the workforce in primary care settings. J Psychoactive Drugs. 2012 Sep-Oct; 44(4):292-8. PMID: 23210377.
      View in: PubMed
    43. Farabee D, Cousins SJ, Brecht ML, Antonini VP, Lee AB, Brummer J, Hemberg J, Karno M, Rawson RA. A comparison of four telephone-based counseling styles for recovering stimulant users. Psychol Addict Behav. 2013 Mar; 27(1):223-9. PMID: 22867295; PMCID: PMC3500433.
    44. Elkashef A, Kahn R, Yu E, Iturriaga E, Li SH, Anderson A, Chiang N, Ait-Daoud N, Weiss D, McSherry F, Serpi T, Rawson R, Hrymoc M, Weis D, McCann M, Pham T, Stock C, Dickinson R, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Li MD, Johnson BA. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial. Addiction. 2012 Jul; 107(7):1297-306. PMID: 22221594; PMCID: PMC3331916.
    45. Evans E, Pierce J, Li L, Rawson R, Hser YI. More alike than different: health needs, services utilization, and outcomes of Asian American and Pacific Islander (AAPI) populations treated for substance use disorders. J Ethn Subst Abuse. 2012; 11(4):318-38. PMID: 23216439; PMCID: PMC3526835.
    46. Urada D, Rutkowski BA, Rawson RA, Freese TE. Editors' introduction: Identifying and assessing promising practices for criminal justice clients--California Substance Abuse Research Consortium (SARC) meetings, 2010. J Psychoactive Drugs. 2011 Sep; Suppl 7:3-9. PMID: 22185034.
      View in: PubMed
    47. Anderson AL, Li SH, Biswas K, McSherry F, Holmes T, Iturriaga E, Kahn R, Chiang N, Beresford T, Campbell J, Haning W, Mawhinney J, McCann M, Rawson R, Stock C, Weis D, Yu E, Elkashef AM. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):135-41. PMID: 21840138.
      View in: PubMed
    48. Baser O, Chalk M, Rawson R, Gastfriend DR. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence. Am J Manag Care. 2011 Jun; 17 Suppl 8:S222-34. PMID: 21761948.
      View in: PubMed
    49. Gonzales R, Ang A, Glik DC, Rawson RA, Lee S, Iguchi MY. Quality of life among treatment seeking methamphetamine-dependent individuals. Am J Addict. 2011 Jul-Aug; 20(4):366-72. PMID: 21679268; PMCID: PMC4026308.
    50. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R. Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment. Eat Disord. 2011 May-Jun; 19(3):259-69. PMID: 21516550; PMCID: PMC3159413.
    51. Dickerson DL, Spear S, Marinelli-Casey P, Rawson R, Li L, Hser YI. American indians/alaska natives and substance abuse treatment outcomes: positive signs and continuing challenges. J Addict Dis. 2011 Jan; 30(1):63-74. PMID: 21218312; PMCID: PMC3042549.
    52. Gonzales R, Brecht ML, Mooney L, Rawson RA. Prescription and over-the-counter drug treatment admissions to the California public treatment system. J Subst Abuse Treat. 2011 Apr; 40(3):224-9. PMID: 21193282; PMCID: PMC4018412.
    53. Zorick T, Nestor L, Miotto K, Sugar C, Hellemann G, Scanlon G, Rawson R, London ED. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction. 2010 Oct; 105(10):1809-18. PMID: 20840201; PMCID: PMC3071736.
    54. Tomás-Rosselló J, Rawson RA, Zarza MJ, Bellows A, Busse A, Saenz E, Freese T, Shawkey M, Carise D, Ali R, Ling W. United Nations Office on Drugs and Crime International Network of Drug Dependence Treatment and Rehabilitation Resource Centres: Treatnet. Subst Abus. 2010 Oct; 31(4):251-63. PMID: 21038179.
      View in: PubMed
    55. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R. Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. Am J Addict. 2010 Sep-Oct; 19(5):385-90. PMID: 20716300; PMCID: PMC3159418.
    56. Davoudi M, Rawson RA. Screening, brief intervention, and referral to treatment (SBIRT) initiatives in California: notable trends, challenges, and recommendations. J Psychoactive Drugs. 2010 Sep; Suppl 6:239-48. PMID: 21138200.
      View in: PubMed
    57. Crèvecoeur-MacPhail D, Bellows A, Rutkowski BA, Ransom L, Myers AC, Rawson RA. "I've been NIATxed": participants' experience with process improvement. J Psychoactive Drugs. 2010 Sep; Suppl 6:249-59. PMID: 21138201.
      View in: PubMed
    58. Herbeck DM, Gonzales R, Rawson RA. Performance improvement in addiction treatment: efforts in California. J Psychoactive Drugs. 2010 Sep; Suppl 6:261-8. PMID: 21138202.
      View in: PubMed
    59. Crèvecoeur-MacPhail D, Ransom L, Myers AC, Annon JJ, Diep N, Gonzales R, Rawson RA, Viemes J, Sugita W, Barger J. Inside the black box: measuring addiction treatment services and their relation to outcomes. J Psychoactive Drugs. 2010 Sep; Suppl 6:269-76. PMID: 21138203.
      View in: PubMed
    60. Rawson RA, Gonzales R, Crèvecoeur-MacPhail D, Urada D, Brecht ML, Chalk M, Kemp J, Cunningham M. Improving the accountability of California's public substance abuse treatment system through the implementation of performance models. J Psychoactive Drugs. 2010 Sep; Suppl 6:211-4. PMID: 21138197.
      View in: PubMed
    61. Rutkowski BA, Rawson RA, Freese TE. Improving the addiction treatment system in California through the use of data and evidence-based practices--California Substance Abuse Research Consortium (SARC) meetings, 2009 [editorial] J Psychoactive Drugs. 2010 Sep; Suppl 6:207-10. PMID: 21138196.
      View in: PubMed
    62. Glasner-Edwards S, Rawson R. Evidence-based practices in addiction treatment: review and recommendations for public policy. Health Policy. 2010 Oct; 97(2-3):93-104. PMID: 20557970; PMCID: PMC2951979.
    63. Rawson RA, Gonzales R. Commentary on Marshall et al. (2010): are long-term negative health consequences of methamphetamine use important to youth? Addiction. 2010 Jun; 105(6):1003-4. PMID: 20659060; PMCID: PMC4074535.
    64. Momtazi S, Rawson R. Substance abuse among Iranian high school students. Curr Opin Psychiatry. 2010 May; 23(3):221-6. PMID: 20308905.
      View in: PubMed
    65. Rutkowski BA, Gallon S, Rawson RA, Freese TE, Bruehl A, Crèvecoeur-MacPhail D, Sugita W, Molfenter T, Cotter F. Improving client engagement and retention in treatment: the Los Angeles County experience. J Subst Abuse Treat. 2010 Jul; 39(1):78-86. PMID: 20409672.
      View in: PubMed
    66. Shetty V, Mooney LJ, Zigler CM, Belin TR, Murphy D, Rawson R. The relationship between methamphetamine use and increased dental disease. J Am Dent Assoc. 2010 Mar; 141(3):307-18. PMID: 20194387; PMCID: PMC2947197.
    67. Gonzales R, Mooney L, Rawson RA. The methamphetamine problem in the United States. Annu Rev Public Health. 2010; 31:385-98. PMID: 20070191; PMCID: PMC4440680.
    68. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson RA. Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev. 2010 Jan; 29(1):12-20. PMID: 20078677; PMCID: PMC3772133.
    69. Sodano R, Watson DW, Rataemane S, Rataemane L, Ntlhe N, Rawson R. The Substance Abuse Treatment Workforce of South Africa. Int J Ment Health Addict. 2010 Oct; 8(4):608-615. PMID: 21037947.
      View in: PubMed
    70. Mooney LJ, Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, Ang A, Hunter J, Haning W, Colescott P, Ling W, Rawson R. Health conditions in methamphetamine-dependent adults 3 years after treatment. J Addict Med. 2009 Sep; 3(3):155-63. PMID: 21769012.
      View in: PubMed
    71. Gonzales R, Ang A, Marinelli-Casey P, Glik DC, Iguchi MY, Rawson RA. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period. J Subst Abuse Treat. 2009 Dec; 37(4):353-61. PMID: 19553066.
      View in: PubMed
    72. Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, Ang A, Mooney LJ, Rawson R. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. J Nerv Ment Dis. 2009 Apr; 197(4):225-31. PMID: 19363377; PMCID: PMC2749575.
    73. Roll JM, Madden GJ, Rawson R, Petry NM. Facilitating the adoption of contingency management for the treatment of substance use disorders. Behav Anal Pract. 2009; 2(1):4-13. PMID: 22477692; PMCID: PMC2854061.
    74. Spear S, Tillman S, Moss C, Gong-Guy E, Ransom L, Rawson RA. Another Way of Talking About Substance Abuse: Substance Abuse Screening and Brief Intervention in a Mental Health Clinic. J Hum Behav Soc Environ. 2009; 19(8):959-977. PMID: 21765630.
      View in: PubMed
    75. Messina N, Marinelli-Casey P, Hillhouse M, Rawson R, Hunter J, Ang A. Childhood adverse events and methamphetamine use among men and women. J Psychoactive Drugs. 2008 Nov; Suppl 5:399-409. PMID: 19248397.
      View in: PubMed
    76. Rutkowski B, Freese T, Rawson R. Editors' introduction: California Substance Abuse Research Consortium, 2007: a focus on women. J Psychoactive Drugs. 2008 Nov; Suppl 5:321-3. PMID: 19248391.
      View in: PubMed
    77. Gonzales R, Marinelli-Casey P, Hillhouse M, Hunter J, Rawson RA, Mooney L, Ang A. Hepatitis A and B infection among methamphetamine-dependent users. J Subst Abuse Treat. 2008 Oct; 35(3):351-2. PMID: 18640808.
      View in: PubMed
    78. Lee NK, Rawson RA. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev. 2008 May; 27(3):309-17. PMID: 18368613.
      View in: PubMed
    79. Rawson RA, Gonzales R, Pearce V, Ang A, Marinelli-Casey P, Brummer J. Methamphetamine dependence and human immunodeficiency virus risk behavior. J Subst Abuse Treat. 2008 Oct; 35(3):279-84. PMID: 18329225; PMCID: PMC2630179.
    80. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R. Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up. Am J Addict. 2008 Mar-Apr; 17(2):99-102. PMID: 18393051.
      View in: PubMed
    81. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R. Clinical course and outcomes of methamphetamine-dependent adults with psychosis. J Subst Abuse Treat. 2008 Dec; 35(4):445-50. PMID: 18294802.
      View in: PubMed
    82. Gonzales R, Ang A, McCann MJ, Rawson RA. An emerging problem: methamphetamine abuse among treatment seeking youth. Subst Abus. 2008; 29(2):71-80. PMID: 19042326.
      View in: PubMed
    83. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R. Risk factors for suicide attempts in methamphetamine-dependent patients. Am J Addict. 2008 Jan-Feb; 17(1):24-7. PMID: 18214719.
      View in: PubMed
    84. Crèvecoeur D, Rutkowski B, Rawson RA. The rise in treatment admissions for methamphetamine use in Los Angeles County from 2001 through 2005. J Psychoactive Drugs. 2007 Nov; Suppl 4:383-92. PMID: 18284104.
      View in: PubMed
    85. Rawson RA, Maxwell J, Rutkowski B. OxyContin abuse: who are the users? Am J Psychiatry. 2007 Nov; 164(11):1634-6. PMID: 17974924.
      View in: PubMed
    86. Anglin MD, Urada D, Brecht ML, Hawken A, Rawson R, Longshore D. Criminal justice itreatment admissions for methamphetamine use in California: a focus on Proposition 36. J Psychoactive Drugs. 2007 Nov; Suppl 4:367-81. PMID: 18284103.
      View in: PubMed
    87. Rawson RA, Gonzales R, McCann M, Ling W. Use of methamphetamine by young people: is there reason for concern? Addiction. 2007 Jul; 102(7):1021-2. PMID: 17567381.
      View in: PubMed
    88. Rawson RA, Gonzales R, Marinelli-Casey P, Ang A. Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment. Am J Addict. 2007 Jul-Aug; 16(4):291-9. PMID: 17661197.
      View in: PubMed
    89. Marinelli-Casey P, Gonzales R, Hillhouse M, Ang A, Zweben J, Cohen J, Hora PF, Rawson RA. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes. J Subst Abuse Treat. 2008 Mar; 34(2):242-8. PMID: 17596903.
      View in: PubMed
    90. Elkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, Smith EV, Chiang N, Kahn R, Vocci F, Ling W, Pearce VJ, McCann M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology. 2008 Apr; 33(5):1162-70. PMID: 17581531.
      View in: PubMed
    91. Rawson RA, Condon TP. Why do we need an Addiction supplement focused on methamphetamine? Addiction. 2007 Apr; 102 Suppl 1:1-4. PMID: 17493048.
      View in: PubMed
    92. Hillhouse MP, Marinelli-Casey P, Gonzales R, Ang A, Rawson RA. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction. 2007 Apr; 102 Suppl 1:84-95. PMID: 17493057.
      View in: PubMed
    93. Elkashef A, Rawson RA, Smith E, Pearce V, Flammino F, Campbell J, Donovick R, Gorodetzky C, Haning W, Mawhinney J, McCann M, Weis D, Williams L, Ling W, Vocci F. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity. Addiction. 2007 Apr; 102 Suppl 1:107-13. PMID: 17493059.
      View in: PubMed
    94. Castro F, Rawson RA, Stamper E. Response: TIPsters weigh in: putting good science to work. Sci Pract Perspect. 2007 Apr; 3(2):35-6. PMID: 17514071; PMCID: PMC2851078.
    95. Messina N, Jeter K, Marinelli-Casey P, West K, Rawson R. Children exposed to methamphetamine use and manufacture. Child Abuse Negl. 2014 Nov; 38(11):1872-83. PMID: 17383002; PMCID: PMC3029499.
    96. Isralowitz R, Reznik A, Spear SE, Brecht ML, Rawson RA. Severity of heroin use in Israel: comparisons between native Israelis and former Soviet Union immigrants. Addiction. 2007 Apr; 102(4):630-7. PMID: 17309539.
      View in: PubMed
    97. Spear S, Crèvecoeur DA, Rawson RA, Clark R. The rise in methamphetamine use among American Indians in Los Angeles County. Am Indian Alsk Native Ment Health Res. 2007; 14(2):1-15. PMID: 17874362.
      View in: PubMed
    98. Ling W, Rawson R, Shoptaw S, Ling W. Management of methamphetamine abuse and dependence. Curr Psychiatry Rep. 2006 Oct; 8(5):345-54. PMID: 16968614.
      View in: PubMed
    99. Gonzales R, Marinelli-Casey P, Shoptaw S, Ang A, Rawson RA. Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment. J Subst Abuse Treat. 2006 Sep; 31(2):195-202. PMID: 16919748.
      View in: PubMed
    100. Hser YI, Stark ME, Paredes A, Huang D, Anglin MD, Rawson R. A 12-year follow-up of a treated cocaine-dependent sample. J Subst Abuse Treat. 2006 Apr; 30(3):219-26. PMID: 16616166.
      View in: PubMed
    101. Rawson RA, McCann MJ, Flammino F, Shoptaw S, Miotto K, Reiber C, Ling W. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction. 2006 Feb; 101(2):267-74. PMID: 16445555.
      View in: PubMed
    102. Venneman S, Leuchter A, Bartzokis G, Beckson M, Simon SL, Schaefer M, Rawson R, Newton T, Cook IA, Uijtdehaage S, Ling W. Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. J Neuropsychiatry Clin Neurosci. 2006; 18(2):208-16. PMID: 16720798.
      View in: PubMed
    103. Spear SE, Brown AH, Rawson RA. "Painting a picture of the client": implementing the Addiction Severity Index in community treatment programs. J Subst Abuse Treat. 2005 Dec; 29(4):277-82. PMID: 16311180.
      View in: PubMed
    104. Rawson RA, Gonzales R, Obert JL, McCann MJ, Brethen P. Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response. J Subst Abuse Treat. 2005 Sep; 29(2):67-74. PMID: 16135335.
      View in: PubMed
    105. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, Thompson PM, Brody AL, Geaga JA, Hong MS, Hayashi KM, Rawson RA, Ling W. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry. 2005 Nov 15; 58(10):770-8. PMID: 16095568.
      View in: PubMed
    106. Longshore D, Annon J, Anglin MD, Rawson RA. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use. Addiction. 2005 Aug; 100(8):1131-9. PMID: 16042643.
      View in: PubMed
    107. Isralowitz R, Rawson R. Gender differences in prevalence of drug use among high risk adolescents in Israel. Addict Behav. 2006 Feb; 31(2):355-8. PMID: 15950393.
      View in: PubMed
    108. Shoptaw S, Watson DW, Reiber C, Rawson RA, Montgomery MA, Majewska MD, Ling W. Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST). Addiction. 2005 Mar; 100 Suppl 1:78-90. PMID: 15730352.
      View in: PubMed
    109. Simon SL, Dacey J, Glynn S, Rawson R, Ling W. The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat. 2004 Jul; 27(1):59-66. PMID: 15223095.
      View in: PubMed
    110. Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway GP, Herrell J, Huber A, McCann MJ, Obert J, Pennell S, Reiber C, Vandersloot D, Zweben J. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004 Jun; 99(6):708-17. PMID: 15139869.
      View in: PubMed
    111. Ling W, Cunningham-Rathner J, Rawson R. Diffusion of substance abuse treatment: will buprenorphine be a success? J Psychoactive Drugs. 2004 May; Suppl 2:115-7. PMID: 15279123.
      View in: PubMed
    112. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004 Jan; 61(1):73-84. PMID: 14706946.
      View in: PubMed
    113. Stizer ML, Owen PL, Hall SM, Rawson RA, Petry NM. CPDD Policy statement. Standards for drug abuse treatment providers. Drug Alcohol Depend. 2003 Aug 20; 71(2):213-5. PMID: 14510012.
      View in: PubMed
    114. Messina N, Farabee D, Rawson R. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions. J Consult Clin Psychol. 2003 Apr; 71(2):320-9. PMID: 12699026.
      View in: PubMed
    115. Ling W, Rawson RA, Compton M. Clinical treatment of opioid addiction and dependence. Methods Mol Med. 2003; 84:285-95. PMID: 12703332.
      View in: PubMed
    116. Farabee D, Rawson R, McCann M. Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. J Subst Abuse Treat. 2002 Dec; 23(4):343-50. PMID: 12495796.
      View in: PubMed
    117. Rawson RA, Marinelli-Casey P, Ling W. Dancing with strangers: will U.S. substance abuse practice and research organizations build mutually productive relationships? Addict Behav. 2002 Nov-Dec; 27(6):941-9. PMID: 12369477.
      View in: PubMed
    118. Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, Rawson RA, Ling W. Smoking cessation in methadone maintenance. Addiction. 2002 Oct; 97(10):1317-28; discussion 1325. PMID: 12359036.
      View in: PubMed
    119. Obert JL, London ED, Rawson RA. Incorporating brain research findings into standard treatment: an example using the Matrix Model. J Subst Abuse Treat. 2002 Sep; 23(2):107-13. PMID: 12220608.
      View in: PubMed
    120. Reiber C, Ramirez A, Parent D, Rawson RA. Predicting treatment success at multiple timepoints in diverse patient populations of cocaine-dependent individuals. Drug Alcohol Depend. 2002 Sep 01; 68(1):35-48. PMID: 12167551.
      View in: PubMed
    121. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, Ling W. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry. 2002 Sep; 59(9):817-24. PMID: 12215081.
      View in: PubMed
    122. Rawson RA, Gonzales R, Brethen P. Treatment of methamphetamine use disorders: an update. J Subst Abuse Treat. 2002 Sep; 23(2):145-50. PMID: 12220612.
      View in: PubMed
    123. Marinelli-Casey P, Domier CP, Rawson RA. The gap between research and practice in substance abuse treatment. Psychiatr Serv. 2002 Aug; 53(8):984-7. PMID: 12161673.
      View in: PubMed
    124. Rawson RA, Washton A, Domier CP, Reiber C. Drugs and sexual effects: role of drug type and gender. J Subst Abuse Treat. 2002 Mar; 22(2):103-8. PMID: 11932136.
      View in: PubMed
    125. Miotto K, McCann M, Basch J, Rawson R, Ling W. Naltrexone and dysphoria: fact or myth? Am J Addict. 2002; 11(2):151-60. PMID: 12028745.
      View in: PubMed
    126. Rawson RA, Obert JL. The substance abuse treatment system in the U.S. What is it? What does it do? Myths and misconceptions. Occup Med. 2002 Jan-Mar; 17(1):27-39, iii-iv. PMID: 11726334.
      View in: PubMed
    127. Rawson RA, Simon SL, Ling W. If a US drug abuse epidemic fails to include a major east coast city, can it be called an epidemic? J Addict Dis. 2002; 21(1):1-4. PMID: 11831495.
      View in: PubMed
    128. Rawson RA, Huber A, Brethen P, Obert J, Gulati V, Shoptaw S, Ling W. Status of methamphetamine users 2-5 years after outpatient treatment. J Addict Dis. 2002; 21(1):107-19. PMID: 11831496.
      View in: PubMed
    129. Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson RA, Ling W. A comparison of patterns of methamphetamine and cocaine use. J Addict Dis. 2002; 21(1):35-44. PMID: 11831498.
      View in: PubMed
    130. Rawson RA, Anglin MD, Ling W. Will the methamphetamine problem go away? J Addict Dis. 2002; 21(1):5-19. PMID: 11831500.
      View in: PubMed
    131. Sim T, Simon SL, Domier CP, Richardson K, Rawson RA, Ling W. Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology. J Addict Dis. 2002; 21(1):75-89. PMID: 11831502.
      View in: PubMed
    132. Simon SL, Domier CP, Sim T, Richardson K, Rawson RA, Ling W. Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis. 2002; 21(1):61-74. PMID: 11831501.
      View in: PubMed